Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial
| Autor: | Shu-Fang Hsu-Schmitz, Marco Collenberg, Regula Everts, Ralph I. Hassink, Maja Steinlin, A Thurneysen, Katharina Fuhrer, Heiner Frei, Franz Kaufmann, Daniel Walther, Klaus von Ammon |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty Randomization Adolescent 610 Medicine & health Neuropsychological Tests Impulsivity Placebo law.invention 510 Mathematics Randomized controlled trial Double-Blind Method law 360 Social problems & social services mental disorders medicine Attention deficit hyperactivity disorder Humans Psychiatry Child Cross-Over Studies business.industry Homeopathy medicine.disease Crossover study Clinical trial Attention Deficit Disorder with Hyperactivity Pediatrics Perinatology and Child Health Materia Medica Female medicine.symptom business |
| Zdroj: | Frei, Heiner; Everts, Regula; von Ammon, Klaus; Kaufmann, Franz; Walther, Daniel; Hsu, Shu-Fang; Collenberg, Marco; Fuhrer, Katharina; Hassink, Ralph; Steinlin, Maja; Thurneysen, André (2005). Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial. European journal of pediatrics, 164(12), pp. 758-767. Springer-Verlag 10.1007/s00431-005-1735-7 |
| DOI: | 10.1007/s00431-005-1735-7 |
| Popis: | An increasing number of parents turn to homeopathy for treatment of their hyperactive child. Two publications, a randomised, partially blinded trial and a clinical observation study, conclude that homeopathy has positive effects in patients with attention deficit hyperactivity disorder (ADHD). The aim of this study was to obtain scientific evidence of the effectiveness of homeopathy in ADHD. A total of 83 children aged 6–16 years, with ADHD diagnosed using the Diagnostic and Statistical Manual of Mental Disorders-IV criteria, were recruited. Prior to the randomised, double blind, placebo controlled crossover study, they were treated with individually prescribed homeopathic medications. 62 patients, who achieved an improvement of 50% in the Conners’ Global Index (CGI), participated in the trial. Thirteen patients did not fulfill this eligibility criterion (CGI). The responders were split into two groups and received either verum for 6 weeks followed by placebo for 6 weeks (arm A), or vice-versa (arm B). At the beginning of the trial and after each crossover period, parents reported the CGI and patients underwent neuropsychological testing. The CGI rating was evaluated again at the end of each crossover period and twice in long-term follow-up. At entry to the crossover trial, cognitive performance such as visual global perception , impulsivity and divided attention, had improved significantly under open label treatment ( P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|